Sheila Gujrathi - Net Worth and Insider Trading

Sheila Gujrathi Net Worth

The estimated net worth of Sheila Gujrathi is at least $3 Million dollars as of 2024-05-15. Sheila Gujrathi is the President & CEO of Gossamer Bio Inc and owns about 4,048,242 shares of Gossamer Bio Inc (GOSS) stock worth over $3 Million. Sheila Gujrathi is also the Director of Ventyx Biosciences Inc and owns about 0 shares of Ventyx Biosciences Inc (VTYX) stock worth over $0. Details can be seen in Sheila Gujrathi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sheila Gujrathi has not made any transactions after 2023-03-30 and currently still holds the listed stock(s).

Transaction Summary of Sheila Gujrathi

To

Sheila Gujrathi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sheila Gujrathi owns 5 companies in total, including Turning Point Therapeutics Inc (TPTX) , Gossamer Bio Inc (GOSS) , and Five Prime Therapeutics Inc (FPRX) among others .

Click here to see the complete history of Sheila Gujrathi’s form 4 insider trades.

Insider Ownership Summary of Sheila Gujrathi

Ticker Comapny Transaction Date Type of Owner
TPTX Turning Point Therapeutics Inc 2019-04-16 director
GOSS Gossamer Bio Inc 2019-09-27 director & President & CEO
FPRX Five Prime Therapeutics Inc 2018-05-10 director
2021-06-10 director
2023-03-30 director

Sheila Gujrathi Latest Holdings Summary

Sheila Gujrathi currently owns a total of 2 stocks. Among these stocks, Sheila Gujrathi owns 4,048,242 shares of Gossamer Bio Inc (GOSS) as of September 27, 2019, with a value of $3 Million and a weighting of 100%. Sheila Gujrathi also owns 0 shares of Ventyx Biosciences Inc (VTYX) as of March 30, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of Sheila Gujrathi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GOSS Gossamer Bio Inc 2019-09-27 4,048,242 0.73 2,966,552
VTYX Ventyx Biosciences Inc 2023-03-30 0 4.17 0

Holding Weightings of Sheila Gujrathi


Sheila Gujrathi Form 4 Trading Tracker

According to the SEC Form 4 filings, Sheila Gujrathi has made a total of 1 transactions in Gossamer Bio Inc (GOSS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Gossamer Bio Inc is the acquisition of 10,000 shares on September 27, 2019, which cost Sheila Gujrathi around $168,000.

According to the SEC Form 4 filings, Sheila Gujrathi has made a total of 1 transactions in Ventyx Biosciences Inc (VTYX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ventyx Biosciences Inc is the sale of 100,000 shares on March 30, 2023, which brought Sheila Gujrathi around $3 Million.

Insider Trading History of Sheila Gujrathi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sheila Gujrathi Trading Performance

GuruFocus tracks the stock performance after each of Sheila Gujrathi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sheila Gujrathi is -9.31%. GuruFocus also compares Sheila Gujrathi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sheila Gujrathi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sheila Gujrathi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sheila Gujrathi

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.55
Relative Return to S&P 500(%) 6.5

Sheila Gujrathi Ownership Network

Ownership Network List of Sheila Gujrathi

No Data

Ownership Network Relation of Sheila Gujrathi


Sheila Gujrathi Owned Company Details

What does Turning Point Therapeutics Inc do?

Who are the key executives at Turning Point Therapeutics Inc?

Sheila Gujrathi is the director of Turning Point Therapeutics Inc. Other key executives at Turning Point Therapeutics Inc include EVP & Chief Financial Officer Paolo Tombesi , SVP & Chief Commercial Officer Steve M Sabus , and SVP & General Counsel Brian Sun .

Turning Point Therapeutics Inc (TPTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Turning Point Therapeutics Inc Insider Transactions

No Available Data

Sheila Gujrathi Mailing Address

Above is the net worth, insider trading, and ownership report for Sheila Gujrathi. You might contact Sheila Gujrathi via mailing address: 10835 Road To The Cure, Suite 205, San Diego Ca 92121.

Discussions on Sheila Gujrathi

No discussions yet.